Article info
PDFLeading article
The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
- Correspondence to Dr Silvio Danese, Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milano, Lombardia, Italy; sdanese{at}hotmail.com
Citation
The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
Publication history
- Received January 23, 2022
- Accepted June 2, 2022
- First published June 14, 2022.
Online issue publication
May 11, 2023
Article Versions
- Previous version (7 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.